INVO Bioscience (INVO) Competitors $0.38 +0.00 (+0.05%) As of 02/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INVO vs. CTCX, TNON, SNOA, SINT, AMIX, GMVDF, VERO, BJDX, STSS, and AVGRShould you be buying INVO Bioscience stock or one of its competitors? The main competitors of INVO Bioscience include Carmell (CTCX), Tenon Medical (TNON), Sonoma Pharmaceuticals (SNOA), Sintx Technologies (SINT), Autonomix Medical (AMIX), G Medical Innovations (GMVDF), Venus Concept (VERO), Bluejay Diagnostics (BJDX), Sharps Technology (STSS), and Avinger (AVGR). These companies are all part of the "surgical & medical instruments" industry. INVO Bioscience vs. Carmell Tenon Medical Sonoma Pharmaceuticals Sintx Technologies Autonomix Medical G Medical Innovations Venus Concept Bluejay Diagnostics Sharps Technology Avinger Carmell (NASDAQ:CTCX) and INVO Bioscience (NASDAQ:INVO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, community ranking, media sentiment and dividends. Which has more risk & volatility, CTCX or INVO? Carmell has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, INVO Bioscience has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Do insiders and institutionals hold more shares of CTCX or INVO? 24.2% of Carmell shares are owned by institutional investors. Comparatively, 12.0% of INVO Bioscience shares are owned by institutional investors. 29.0% of Carmell shares are owned by insiders. Comparatively, 3.5% of INVO Bioscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer CTCX or INVO? INVO Bioscience received 7 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformCarmellN/AN/AINVO BioscienceOutperform Votes746.67% Underperform Votes853.33% Is CTCX or INVO more profitable? Carmell has a net margin of 0.00% compared to INVO Bioscience's net margin of -122.79%. INVO Bioscience's return on equity of 0.00% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets CarmellN/A -217.50% -50.22% INVO Bioscience -122.79%N/A -36.94% Does the media favor CTCX or INVO? In the previous week, Carmell's average media sentiment score of 0.00 equaled INVO Bioscience'saverage media sentiment score. Company Overall Sentiment Carmell Neutral INVO Bioscience Neutral Which has preferable valuation and earnings, CTCX or INVO? INVO Bioscience has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarmellN/AN/A-$15.44MN/AN/AINVO Bioscience$5.77M0.25-$8.03MN/AN/A SummaryINVO Bioscience beats Carmell on 6 of the 9 factors compared between the two stocks. Get INVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INVO vs. The Competition Export to ExcelMetricINVO BioscienceSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.45M$4.71B$5.84B$9.13BDividend YieldN/A39.90%4.75%3.86%P/E RatioN/A30.1926.7919.19Price / Sales0.2555.33434.5471.84Price / CashN/A51.1038.0134.83Price / Book-0.186.577.644.62Net Income-$8.03M$90.91M$3.19B$246.06M7 Day Performance8.66%-2.39%-2.12%-2.62%1 Month Performance-16.77%-2.66%-1.11%-2.57%1 Year Performance-62.36%15.87%15.71%12.72% INVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INVOINVO BioscienceN/A$0.38+0.1%N/A-58.7%$1.45M$5.77M0.0025Gap UpCTCXCarmellN/A$0.25+2.5%N/A-92.2%$5.14MN/A0.0014TNONTenon Medical1.6827 of 5 stars$1.46flat$5.50+276.7%+28.7%$4.58M$3.32M-0.058SNOASonoma Pharmaceuticals0.1975 of 5 stars$2.49-5.0%N/A+1,456.0%$4.03M$12.73M-0.62180SINTSintx Technologies0.9952 of 5 stars$2.95-0.7%N/A-81.0%$3.95M$2.63M-0.0640News CoverageGap DownAMIXAutonomix Medical1.7186 of 5 stars$2.84-0.4%$28.00+885.9%-96.3%$3.27MN/A-0.181News CoverageGMVDFG Medical InnovationsN/AN/AN/AN/A$2.60M$4.42M0.0072VEROVenus ConceptN/A$0.33-1.0%N/A-83.3%$2.41M$76.35M-0.04410Negative NewsBJDXBluejay DiagnosticsN/A$3.55-5.0%N/A-98.9%$1.96M$250,000.000.009Negative NewsSTSSSharps Technology0.2961 of 5 stars$0.35-4.2%N/AN/A$1.92MN/A-0.043Negative NewsAVGRAvinger3.0715 of 5 stars$0.47-20.7%$5.00+954.9%N/A$1.57M$7.65M-0.0470Analyst ForecastGap DownHigh Trading Volume Related Companies and Tools Related Companies Carmell Competitors Tenon Medical Competitors Sonoma Pharmaceuticals Competitors Sintx Technologies Competitors Autonomix Medical Competitors G Medical Innovations Competitors Venus Concept Competitors Bluejay Diagnostics Competitors Sharps Technology Competitors Avinger Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INVO) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INVO Stock Alerts